Non-alcoholic fatty liver disease and cardiovascular risk

被引:76
作者
Brea, Angel [1 ]
Puzo, Jose [2 ]
机构
[1] Hosp San Pedro, Unidad Lipidos, Serv Med Interna, Logrono, Spain
[2] Hosp San Jorge, Unidad Lipidos, Bioquim Clin, Huesca, Spain
关键词
Fatty liver; Cardiovascular disease; Alcohol; Non-alcoholic fatty liver disease; GAMMA-GLUTAMYL-TRANSFERASE; CORONARY-HEART-DISEASE; TRIGLYCERIDE TRANSFER PROTEIN; ENDOPLASMIC-RETICULUM STRESS; RANDOMIZED CONTROLLED-TRIAL; TERM-FOLLOW-UP; HEPATIC STEATOSIS; METABOLIC SYNDROME; INSULIN-RESISTANCE; WEIGHT-LOSS;
D O I
10.1016/j.ijcard.2012.09.085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The term "Non-alcoholic fatty liver disease" (NAFLD) covers a series of liver lesions similar to those induced by alcohol, but not caused by alcohol use. The importance of NAFLD lies in the high prevalence in Western societies and, from the point of view of the liver, in its progression from steatosis to cirrhosis and liver cancer. More recently, NAFLD has been found to be associated with lipid metabolism disorders, the deposition of fat outside of the adipocytes, insulin resistance and Metabolic Syndrome. Also attributed to NAFLD is a heightened systemic pro-inflammatory state, which accelerates arteriosclerosis, thereby increasing cardiovascular risk and associated cardiovascular events. Here we provide an update to the etiopathogenesis of NAFLD, its influence on cardiovascular disease, and the treatment options. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1109 / 1117
页数:9
相关论文
共 157 条
[1]   The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]   Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis [J].
Adams, Leon A. ;
Feldstein, Ariel E. .
JOURNAL OF DIGESTIVE DISEASES, 2011, 12 (01) :10-16
[3]   Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study [J].
Adams, Leon A. ;
Harmsen, Scott ;
St Sauver, Jennifer L. ;
Charatcharoenwitthaya, Phunchai ;
Enders, Felicity B. ;
Therneau, Terry ;
Angulo, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (07) :1567-1573
[4]   Overproduction of large VLDL particles is driven by increased liver fat content in man [J].
Adiels, M ;
Taskinen, MR ;
Packard, C ;
Caslake, MJ ;
Soro-Paavonen, A ;
Westerbacka, J ;
Vehkavaara, S ;
Hakkinen, A ;
Olofsson, SO ;
Yki-Jarvinen, H ;
Borén, J .
DIABETOLOGIA, 2006, 49 (04) :755-765
[5]   The Inflamed Liver and Atherosclerosis: A Link Between Histologic Severity of Nonalcoholic Fatty Liver Disease and Increased Cardiovascular Risk [J].
Alkhouri, Naim ;
Tamimi, Tarek Abu-Rajab ;
Yerian, Lisa ;
Lopez, Rocio ;
Zein, Nizar N. ;
Feldstein, Ariel E. .
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (09) :2644-2650
[6]   HEPATIC-EFFECTS OF DIETARY WEIGHT-LOSS IN MORBIDLY OBESE SUBJECTS [J].
ANDERSEN, T ;
GLUUD, C ;
FRANZMANN, MB ;
CHRISTOFFERSEN, P .
JOURNAL OF HEPATOLOGY, 1991, 12 (02) :224-229
[7]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[8]   Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients [J].
Antonopoulos, S ;
Mikros, S ;
Mylonopoulou, M ;
Kokkoris, S ;
Giannoulis, G .
ATHEROSCLEROSIS, 2006, 184 (01) :233-234
[9]   Association between nonalcoholic fatty liver disease and coronary artery disease [J].
Arslan, Ugur ;
Tuerkoglu, Sedat ;
Balcioglu, Serhat ;
Tavil, Yusuf ;
Karakan, Tarkan ;
Cengel, Atiye .
CORONARY ARTERY DISEASE, 2007, 18 (06) :433-436
[10]   Fatty infiltration of liver in hyperlipidemic patients [J].
Assy, N ;
Kaita, K ;
Mymin, D ;
Levy, C ;
Rosser, B ;
Minuk, G .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (10) :1929-1934